Stock Price Quote

NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE2090.10-12.25 (-0.58 %)
PREV CLOSE ( ) 2102.35
OPEN PRICE ( ) 2106.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 583
TODAY'S LOW / HIGH ( )2068.60 2109.05
52 WK LOW / HIGH ( )1171 2425.1
NSE2094.00-15.65 (-0.74 %)
PREV CLOSE( ) 2109.65
OPEN PRICE ( ) 2149.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5063
TODAY'S LOW / HIGH( ) 2080.00 2166.45
52 WK LOW / HIGH ( )1177.55 2439.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1981
Management Info
- Chairman Rahul J Nachane - Managing Director
Registered Office

Address 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone 022 26636450

Email info@nglfinechem.com

Website www.nglfinechem.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, NSE

NEWS

19Mar Appointment of Director
Inter alia, approved:- 1) Appointment of Mr. Dhananjay Mungale (DIN: 00..
19Mar Notice of Postal Ballot
Inter alia, approved:- 1) Appointment of Mr. Dhananjay Mungale (DIN: 00..
19Mar NGL Fine-Chem submits postal ballot no
With reference to its earlier announcement dated March 18, 2024, wherein..
11Mar NGL Fine-Chem informs about board meet
NGL Fine-Chem has informed that the fifth Board Meeting for the financia..
11Mar Appointment of Director
Inter alia to consider and approve: (1) Appointment of Mr. Dhananjay Mu..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit88.96201.19
Gross Profit 127.96 266
Operating Profit 151.38356.96
Net Sales 848.122750.52

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26946.00 (0.74%)
M.Cap ( in Cr)57258.37
Sanofi India (BSE)
peergroup  8118.25 (2.06%)
M.Cap ( in Cr)18696.83
Dr. Reddy's Lab (BSE)
peergroup  6155.15 (1.78%)
M.Cap ( in Cr)102679.14
Divi's Lab (BSE)
peergroup  3436.75 (2.14%)
M.Cap ( in Cr)91234.91
Glaxosmithkline Phar (BSE)
peergroup  1943.10 (3.26%)
M.Cap ( in Cr)32917.29

Shareholding Pattern

PROMOTERS 73.06%
NON-INSTITUTION 26.9%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About NGL Fine-Chem Ltd.

NGL Fine-Chem Ltd. was incorporated in the year 1981. Its today's share price is 2090.1. Its current market capitalisation stands at Rs 1291.27 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2750.53 Cr and Total Income of Rs.2826.65 Cr. The company's management includes Dhananjay Mungale, Pallavi Pednekar, Rajesh N Lawande, Rahul J Nachane, Sarala Menon, Milind V Shinde, Jayaram Sitaram, Ajita Nachane.

It is listed on the BSE with a BSE Code of 524774 , NSE with an NSE Symbol of NGLFINE and ISIN of INE887E01022. It's Registered office is at 301 E Square,Subhash Road,Vile Parle (East)Mumbai-400057, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bharat Gandhi & Co, Manek & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.